Eren Gunertem

Dr. Eren Gunertem


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in Perfusion
Verified
Journal Article
Open access
GAGianni Angelini
Gianni Angelini
BRBarnaby C Reeves
Barnaby C Reeves
LCLucy A Culliford
Lucy A Culliford
RMRachel Maishman
Rachel Maishman
CRChris A Rogers
Chris A Rogers
SDSarah Dennis
Sarah Dennis
Introduction: The trial hypothesized that minimally invasive extra-corporeal circulation (MiECC) reduces the risk of serious adverse events (SAEs) after cardiac surgery operations requiring extra-corporeal circulation without circulatory arrest. Methods: This is a multicentre, international randomized controlled trial across fourteen cardiac surgery centres including patients aged ≥18 and <85 years undergoing elective or urgent isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR) surgery, or CABG + AVR surgery. Participants were randomized to MiECC or conventional extra-corporeal circulation (CECC), stratified by centre and operation. The primary outcome was a composite of 12 post-operative SAEs up to 30 days after surgery, the risk of which MiECC was hypothesized to reduce. Secondary outcomes comprised: other SAEs; all-cause mortality; transfusion of blood products; time to discharge from intensive care and hospital; health-related quality-of-life. Analyses were performed on a modified intention-to-treat basis. Results: The trial terminated early due to the COVID-19 pandemic; 1071 participants (896 isolated CABG, 97 isolated AVR, 69 CABG + AVR) with median age 66 years and median EuroSCORE II 1.24 were randomized (535 to MiECC, 536 to CECC). Twenty-six participants withdrew after randomization, 22 before and four after intervention. Fifty of 517 (9.7%) randomized to MiECC and 69/522 (13.2%) randomized to CECC group experienced the primary outcome (risk ratio = 0.732, 95% confidence interval (95% CI) = 0.556 to 0.962, p = 0.025). The risk of any SAE not contributing to the primary outcome was similarly reduced (risk ratio = 0.791, 95% CI 0.530 to 1.179, p = 0.250). Conclusions: MiECC reduces the relative risk of primary outcome events by about 25%. The risk of other SAEs was similarly reduced. Because the trial terminated early without achieving the target sample size, these potential benefits of MiECC are uncertain.

10 July 2020 in Perfusion
Verified
Journal Article
Closed access
PDF file
EGEren Gunertem
Eren Gunertem
SUSalim Urcun
Salim Urcun
APArda Aybars Pala
Arda Aybars Pala
ABAli Baran Budak
Ali Baran Budak
MEMurat Abdulhamid Ercisli
Murat Abdulhamid Ercisli
SGSerdar Gunaydin
Serdar Gunaydin
Aim: Postoperative bleeding is a significant cause of morbidity and mortality in patients undergoing cardiac surgery. Studies have been conducted, and guidelines have been published regarding patient blood management and aiming to prevent blood loss in the perioperative period. Various bleeding risk assessments were developed for preoperative period. We aimed to examine the correlations of scoring systems in the literature with the amount of postoperative bleeding in patients undergoing first time coronary artery bypass graft surgery, and to show the most suitable preoperative bleeding risk assessment for coronary artery bypass graft patients. Methods: The study included 550 consecutive patients who underwent coronary artery bypass graft operation. The inclusion criteria were considered as patients to be older than 18 years old and to undergo elective or emergent myocardial revascularization using cardiopulmonary bypass. All variables required for scoring systems were recorded. The initial results of the study were determined as the amount of chest tube drainage, the use of blood products, the change in hematocrit level, reoperation due to bleeding, duration of ventilation, duration of intensive care unit stay, and hospital stay. Mortality which occurred during first 30 days after operation was considered as operative mortality. Operative mortality was accepted as the primary endpoint. Secondary endpoints were massive bleeding and high amount of transfusion. Results: Data were obtained from a series of 550 consecutive patients treated with isolated coronary artery bypass graft. It was seen that PAPWORTH and WILL-BLEED risk assessments responded better for E-CABG grade 2 and 3 bleeding compared to other risk assessments. TRACK, TRUST, and ACTA-PORT scales were found to have low ability to distinguish patients with E-CABG bleeding grade 2 and 3. Conclusion: Predicting postoperative bleeding and transfusion rates with preoperative risk scores in patients undergoing coronary artery bypass graft surgery will provide valuable information to physicians for establishing a proper patient blood management protocol and this will decrease excessive transfusions, unnecessary reoperations as well as improve postoperative outcomes.

1 July 2022 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
ABAli Baran Budak
Ali Baran Budak
EGEren Gunertem
Eren Gunertem
KOKanat Ozisik
Kanat Ozisik
SGSerdar Gunaydin
Serdar Gunaydin

25 June 2020 in Turkish Journal of Vascular Surgery
Verified
Journal Article
Open access
PDF file
EGEren Gunertem
Eren Gunertem
TATankut Akay
Tankut Akay
AAAnar Aliyev
Anar Aliyev
SBSarp Beyazpınar
Sarp Beyazpınar
NENevzat Erdil
Nevzat Erdil
KBKürşat Bozkurt
Kürşat Bozkurt

8 July 2016 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
KCKerim Cagli
Kerim Cagli
EGEren Gunertem
Eren Gunertem
IEIbrahim Erkengel
Ibrahim Erkengel
KCKumral Cagli
Kumral Cagli

16 January 2015 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
GAGarip Altıntas
Garip Altıntas
EGEren Gunertem
Eren Gunertem
HBHasmet Bardakci
Hasmet Bardakci